Nonrandomized Comparison between Concomitant and Sequential Chemoradiotherapy with Anthracyclines in Breast Cancer
暂无分享,去创建一个
A. Luini | R. Orecchia | C. Cipolla | L. Santoro | M. Colleoni | M. Leonardi | B. Jereczek-Fossa | B. Vischioni | C. Fodor | A. Morra | D. Cardinale | A. Ferrari | G. Ivaldi | A. Balduzzi | V. Dell’Acqua
[1] Michel Bolla,et al. Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. , 2008, European journal of cancer.
[2] A. Recht. Phase III Trial of Concurrent or Sequential Adjuvant Chemoradiotherapy After Conservative Surgery for Early-Stage Breast Cancer: Final Results of the ARCOSEIN Trial , 2007 .
[3] A. Neugut,et al. Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. , 2007, International journal of radiation oncology, biology, physics.
[4] H. Bartelink,et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. , 2007, Journal of the National Cancer Institute.
[5] Qifeng Yang,et al. Concurrent chemo-radiation in the conservative management of breast cancer. , 2006, International journal of radiation oncology, biology, physics.
[6] L. Demange,et al. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. , 2006, International journal of radiation oncology, biology, physics.
[7] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[8] R. T. Ten Haken,et al. Body Mass Index Predicts the Incidence of Radiation Pneumonitis in Breast Cancer Patients , 2005, Cancer journal.
[9] H. J. Wallace. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: Updated results of a prospective randomized trial , 2005 .
[10] J. Nortier,et al. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study. , 2003, European journal of cancer.
[11] J. Flickinger,et al. Concurrent sequencing of full-dose CMF chemotherapy and radiation therapy in early breast cancer has no effect on treatment delivery. , 2003, European journal of cancer.
[12] G. Bonadonna,et al. Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] T. Whelan,et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Yarnold,et al. Mixing anthracyclines and radiotherapy in early breast cancer: how safe is it? , 1996, European journal of cancer.
[15] D. Schultz,et al. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy. , 1996, International journal of radiation oncology, biology, physics.
[16] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[17] F. Vicini,et al. Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. , 1991, International journal of radiation oncology, biology, physics.
[18] K. Luk,et al. The reverse hockey stick technique: postmastectomy radiation therapy for breast cancer patients with locally advanced tumor presentation or extensive loco-regional recurrence. , 1989, International journal of radiation oncology, biology, physics.
[19] F. Stockdale,et al. The effect of postoperative and primary radiation therapy on delivered dose of adjuvant Cyclophosphamide, methotrexate, and 5‐fluorouracil (CMF) chemotherapy in breast cancer , 1984, Cancer.